Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.45% |
| 2 | Technology | 8.65% |
| 3 | Financials | 8.6% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Travelers Companies
TRV
$77.5B
| $595K | ﹤0.01% |
4,343
-150,518
| -97% | -$20.5M |
|
|
ADAP
3252
DELISTED
Adaptimmune Therapeutics
ADAP
| $592K | ﹤0.01% |
493,235
-421,181
| -46% | -$449K |
|
3253
Pegasystems
PEGA
$5.54B
| $592K | ﹤0.01% |
+14,870
| New | +$562K |
|
3254
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.67B
| $590K | ﹤0.01% |
5,899
-341
| -5% | -$31.8K |
|
|
EVBG
3255
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $590K | ﹤0.01% |
7,553
-4,857
| -39% | -$375K |
|
|
NWHM
3256
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $590K | ﹤0.01% |
126,676
-74,336
| -37% | -$339K |
|
3257
A10 Networks
ATEN
$1.88B
| $587K | ﹤0.01% |
85,376
+68,963
| +420% | +$464K |
|
3258
Neurogene
NGNE
$802M
| $587K | ﹤0.01% |
2,382
-18,078
| -88% | -$1.8M |
|
|
SBBX
3259
DELISTED
SB One Bancorp Common Stock
SBBX
| $585K | ﹤0.01% |
23,465
+3,177
| +16% | +$73.4K |
|
3260
Atlanta Braves Holdings Series B
BATRK
$3.33B
| $584K | ﹤0.01% |
+19,774
| New | +$563K |
|
3261
CALL
Altria Group
MO
$115B
| $584K | ﹤0.01% |
11,700
-68,300
| -85% | -$3.22M |
|
3262
Shore Bancshares
SHBI
$773M
| $583K | ﹤0.01% |
+33,597
| New | +$549K |
|
3263
Open Text
OTEX
$5.78B
| $581K | ﹤0.01% |
13,177
-613,204
| -98% | -$25.8M |
|
3264
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.8B
| $581K | ﹤0.01% |
+10,848
| New | +$581K |
|
3265
Civeo
CVEO
$347M
| $580K | ﹤0.01% |
37,481
+34,495
| +1,155% | +$432K |
|
3266
Kennametal
KMT
$2.26B
| $580K | ﹤0.01% |
15,717
-307,715
| -95% | -$10.3M |
|
|
ARGO
3267
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $580K | ﹤0.01% |
8,817
-64,110
| -88% | -$4.19M |
|
3268
iShares MSCI Mexico ETF
EWW
$1.81B
| $579K | ﹤0.01% |
12,860
-171,509
| -93% | -$7.61M |
|
|
COHR
3269
DELISTED
Coherent Inc
COHR
| $578K | ﹤0.01% |
+3,475
| New | +$538K |
|
3270
eGain
EGAN
$195M
| $576K | ﹤0.01% |
72,729
-226,733
| -76% | -$1.75M |
|
3271
Integra LifeSciences
IART
$1.3B
| $574K | ﹤0.01% |
9,841
-201,590
| -95% | -$12M |
|
3272
ORIX
IX
$43B
| $574K | ﹤0.01% |
34,435
-22,245
| -39% | -$357K |
|
|
TBHC
3273
DELISTED
The Brand House Collective
TBHC
| $573K | ﹤0.01% |
462,335
-183,016
| -28% | -$245K |
|
3274
Citizens Community Bancorp
CZWI
$202M
| $568K | ﹤0.01% |
46,515
-12,192
| -21% | -$142K |
|
3275
Iridium Communications
IRDM
$4.99B
| $568K | ﹤0.01% |
23,043
+13,644
| +145% | +$327K |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.